Cargando…

Commentary on “Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease”

Detalles Bibliográficos
Autores principales:	Kayadibi, Huseyin, Sertoglu, Erdim, Uyanik, Metin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219150/ https://www.ncbi.nlm.nih.gov/pubmed/25371482 http://dx.doi.org/10.1093/gastro/gou064

Ejemplares similares

Value of neutrophil to lymphocyte ratio as a biomarker in colorectal adenocarcinoma
por: Sertoglu, Erdim, et al.
Publicado: (2016)

Importance of the Selected Cut-Offs for Serum Uric Acid and Lipids Levels
por: Kayadibi, Huseyin, et al.
Publicado: (2014)

Plasma Total Homocysteine Levels in Diabetic Retinopathy
por: Kayadibi, Huseyin, et al.
Publicado: (2014)

Biochemical view on: Precocious markers of cardiovascular risk and vascular damage in apparently healthy women with previous gestational diabetes
por: Kayadibi, Huseyin, et al.
Publicado: (2015)

Comment on “Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio: Novel Markers for Diagnosis and Prognosis in Patients with Idiopathic Sudden Sensorineural Hearing Loss”
por: Sertoglu, Erdim, et al.
Publicado: (2015)

The Evaluation of the Neutrophil-to-Lymphocyte Ratio in Coronary Chronic Total Occlusion
por: Sertoglu, Erdim, et al.
Publicado: (2015)

Accurate use of neutrophil/lymphocyte ratio from the perspective of laboratory experts
por: Sertoglu, Erdim, et al.
Publicado: (2013)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B., et al.
Publicado: (2014)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Is aspartate aminotransferase-to-platelet ratio index a biomarker in the evaluation of advanced fibrosis in non-alcoholic fatty liver disease?
por: Agilli, Mehmet, et al.
Publicado: (2014)

Histological analysis of hypoglycemic agents on liver fibrosis in patients with non-alcoholic fatty liver disease: a systematic review
por: Xie, Qingxing, et al.
Publicado: (2023)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

Underestimation of metabolic unhealthiness and overestimation of non-alcoholic fatty liver disease
por: Sarathi, Vijaya, et al.
Publicado: (2023)

Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease
por: Wang, Jincheng, et al.
Publicado: (2022)

The Relationship of Circulating Fetuin-A With Liver Histology and Biomarkers of Systemic Inflammation in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease
por: Celebi, Gurkan, et al.
Publicado: (2015)

The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B.
Publicado: (2014)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Han, Seul Ki, et al.
Publicado: (2023)

Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Association of serum zinc-α2-glycoprotein with non-alcoholic fatty liver disease
por: Qi, Xiao-Yan, et al.
Publicado: (2020)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2023)

Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools
por: Lang, Sonja, et al.
Publicado: (2020)

Non-Invasive Diagnostic Test for Advanced Fibrosis in Adolescents With Non-Alcoholic Fatty Liver Disease
por: Mosca, Antonella, et al.
Publicado: (2022)

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
por: Gallego-Durán, Rocío, et al.
Publicado: (2016)

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Nogami, Asako, et al.
Publicado: (2023)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
por: Drolz, Andreas, et al.
Publicado: (2021)

Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2 Diabetes
por: Chung, Seung Min, et al.
Publicado: (2023)

Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2023)

Non-invasive tests of non-alcoholic fatty liver disease
por: Li, Guanlin, et al.
Publicado: (2022)

Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022)

Non-invasive assessment of liver fibrosis in alcoholic liver disease
por: Husain, Ayan, et al.
Publicado: (2020)

Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study
por: Ciećko-Michalska, Irena, et al.
Publicado: (2018)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
por: Ghandian, Sina, et al.
Publicado: (2022)

Is non-cardiac death increased with an initial invasive revascularization strategy? Commentary on the ISCHEMIA trial
por: Rodriguez, Alfredo E, et al.
Publicado: (2022)

Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
por: Kechagias, Stergios, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lj0ke8896pi200lgueqiu50pag